Candriam Equities L Biotechnology, V2 - Capitalisation
WKN A3DLGT | ISIN LU2026682919 | Fonds
Fonds
| ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
|---|---|---|---|---|---|---|
| 1 | LU0942225912 | Candriam Equities L Biotechnology, R - Capitalisation | -10,84 % | +19,41 % | -0,68 |
|
| 2 | LU0133360163 | Candriam Equities L Biotechnology, I - Capitalisation | -11,03 % | +19,24 % | -0,70 |
|
| 3 | CH0113817123 | Bellevue Biotech DT CHF | -11,74 % | +19,82 % | -0,71 |
|
| 4 | LU2026682919 | Candriam Equities L Biotechnology, V2 - Capitalisation | -12,90 % | +19,55 % | -0,78 |
|
| 5 | LU0317020203 | Candriam Equities L Biotechnology, V - Capitalisation | -13,20 % | +19,39 % | -0,80 |
|
| 73 | LU0767968745 | Bellevue Funds (Lux) - Bellevue Obesity Solutions I GBP - Accumulating | -11,76 % | +11,29 % | -1,25 |
|
| 74 | LU0415392835 | Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating | -15,58 % | +13,53 % | -1,33 |
|
| 75 | DE000A3DCA95 | BIT Biotech Opportunities S | -38,46 % | +30,62 % | -1,33 |
|
| 76 | LU0415392595 | Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating | -16,17 % | +13,53 % | -1,37 |
|
| 77 | DE000A3DCBA0 | BIT Biotech Opportunities I-II | -38,62 % | +30,61 % | -1,34 |
|